XGN: Exagen Inc. Common Stock Company Profile & Statistics

About

Exagen Inc. is engaged in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases. It developed and commercialises testing products under AVISE brand. Exagen Inc. is based in Vista, California.

Info & Links

CEO

John Aballi

Headquarters

1261 LIBERTY WAY
VISTA, CA 92081, UNITED STATES

Auditor

BDO USA, P.C

Share holders

Employees

209

Exagen Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

72.85M

Enterprise Value

71.06M

Enterprise Value/EBITDA(ttm)

-6.04

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

1.20

Price to Book(mrq)

5.11

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

59.41%

Operating Margin(ttm)

-30.36%

Profit Margin(ttm)

-27.69%

Return on Equity(ttm)

-92.58%

Return on Invested Capital(ttm)

-44.68%

Return on Assets(ttm)

-33.74%

Income Statement

Revenue(ttm)

55.64M

Revenue Per Share(ttm)

3.11

Gross Profit(ttm)

33.11M

EBITDA(ttm)³

-11.76M

Net Income Available to Common(ttm)

-15.11M

Diluted EPS(ttm)

-0.94

Share Statistics

Beta (5Y Monthly)

1.41

52-Week Change

171.33%

S&P 500 52-Week Change

-5.09%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

17.90M

Dividend Yield

0.00%

Float⁴

13.03M

% Held by Insiders

26.10%

% Held by Institutions

75.25%

Balance Sheet

Total Cash(mrq)

22.04M

Total Cash Per Share(mrq)

1.23

Total Debt(mrq)

20.25M

Total Debt/Equity(mrq)

212.21%

Current Ratio(mrq)

2.70%

Quick Ratio(mrq)

4.05%

Book Value Per Share(mrq)

0.54

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.73

Free Cash Flow(ytd)

-13.79M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

XGN

Exagen Inc. Common Stock

Exagen Inc. Common Stock Profile